Long-term study of oral treprostinil to treat pulmonary arterial hypertension: dosing, tolerability, and pharmacokinetics

Oral treprostinil may be an option for low- and intermediate-risk patients with pulmonary arterial hypertension, a rare lung vascular disease. This open-label extension study collected data on participants who completed previously reported, placebo-controlled oral treprostinil studies. Eligible part...

Descripción completa

Detalles Bibliográficos
Autores principales: White, R. James, Parikh, Keyur, Allen, Roblee, Feldman, Jeremy, Jerjez-Sanchez, Carlos, Pan, Lei, Keogh, Anne, Vizza, C. Dario, Shapiro, Shelley, Gordon, Kathryn, Broderick, Meredith, Bartolome, Sonja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731723/
https://www.ncbi.nlm.nih.gov/pubmed/31290359
http://dx.doi.org/10.1177/2045894019866335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731723/
https://www.ncbi.nlm.nih.gov/pubmed/31290359
http://dx.doi.org/10.1177/2045894019866335

Ejemplares similares